BIOHEART-B 02185·

Gross margin ------------------------40.10%-- Net margin -------------------------152.31%-- ROE -52.14%-------36.30%---23.12%13.18%-23.50%0.38%-13.32%10.19%-16.11%2.80% ROA -38.74%-------36.76%---23.52%13.24%-23.09%0.44%-12.72%10.37%-8.22%4.50% Attributable profit growth ------------43.50%--13.88%29.62%50.00%36.12%20.34%29.66% Debt-to-assets 25.71%------7.18%--6.77%0.41%5.38%1.39%7.26%1.87%26.47%19.22% Current ratio 3.54------20.55--18.771.7820.351.5815.225.1315.260.04 Operating cash flow / net profit 0.08------0.22--0.610.390.260.351.271.010.990.28 Operating cash flow / revenue -------------------------150.59%--

Gross margin 46.47%--46.76%0.28% Net margin -128.15%---231.16%103.01% Revenue growth -----31.09%-- Attributable profit growth -----20.02%-- Debt-to-assets ----26.80%-- Current ratio ----23.75--

Revenue ------------------------44.93M-- Other income and gains 1.85M------7.16M--23.78M232.11%8.57M63.97%2.68M68.73%4.61M71.89% Gross profit ------------------------18.02M-- Selling and distribution expenses ------------------------2.84M-- Administrative expenses 3.23M------195.42M--94.37M51.71%52.88M43.96%19.74M62.67%24.98M26.53% Net finance costs 108.00K------685.00K--959.00K40.00%578.00K39.73%64.00K88.93%8.74M13559.38% Income tax 0----------------------27.57M-- Operating profit -586.00K-------409.14M---228.48M44.16%-186.61M18.33%-92.27M50.55%-85.79M7.02% Share of associates and JVs -------------1.43M---1.63M14.20%-986.00K39.62%-1.47M48.78% Profit before tax -10.69M-------409.82M---230.87M43.67%-188.82M18.21%-93.32M50.58%-96.00M2.87% Net profit -10.69M-------409.82M---230.87M43.67%-188.82M18.21%-93.32M50.58%-68.43M26.67% Net profit attributable to owners -10.69M-------361.45M---204.24M43.50%-175.89M13.88%-87.94M50.00%-70.05M20.34%

Revenue 20.86M--14.38M31.09% Other income and gains 764.00K--9.69M1168.19% Cost of sales 11.17M--7.66M31.45% Gross profit 9.70M--6.72M30.67% Selling and distribution expenses 1.15M--1.20M4.45% Administrative expenses 9.69M--7.24M25.34% Net finance costs 6.65M--5.23M21.28% Income tax 686.00K--141.00K79.45% Share of associates and JVs -256.00K--0100.00% Profit before tax -27.42M---33.38M21.72% Net profit -26.73M---33.23M24.31% Net profit attributable to owners -27.21M---32.66M20.02%

Cash and cash equivalents 16.22M------708.53M--451.32M36.30%369.44M18.14%202.39M45.22%92.28M54.40% Trade and bills receivables ------------------------17.84M-- Inventories ----------------3.98M--18.33M360.48%32.18M75.60% Total current assets 19.65M------756.53M--541.53M28.42%408.47M24.57%299.03M26.79%381.91M27.72% Total assets 27.61M------1.11B--981.52M11.96%817.90M16.67%733.78M10.29%832.48M13.45% Total current liabilities 5.54M------36.81M--28.85M21.64%20.07M30.43%19.65M2.09%25.03M27.39% Total liabilities 7.10M------80.04M--66.47M16.96%44.04M33.74%53.24M20.89%220.38M313.91% Equity attributable to owners 20.51M------995.69M--883.21M11.30%748.41M15.26%660.47M11.75%434.81M34.17% Total equity 20.51M------1.03B--915.05M11.58%773.86M15.43%680.53M12.06%612.10M10.06%

Cash and cash equivalents ----92.17M-- Trade and bills receivables ----27.93M-- Inventories ----34.42M-- Total current assets ----363.71M-- Total assets ----790.82M-- Total current liabilities ----15.31M-- Total liabilities ----211.96M-- Equity attributable to owners ----402.15M-- Total equity ----578.87M--

Net cash from operating activities -860.00K-------88.47M---140.62M58.94%-49.03M65.13%-118.44M141.58%-67.67M42.87% Net cash from investing activities 217.00K-------33.73M---100.69M198.49%-28.86M71.34%-47.14M63.36%-195.99M315.76% Net cash from financing activities -1.05M------383.68M---35.18M109.17%-5.82M83.46%-2.44M58.03%153.81M6398.61% Net change in cash -949.00K------261.48M---276.48M205.74%-83.70M69.73%-168.03M100.74%-109.84M34.63%